Polymeric nanoparticles, especially those derived from PLGA (poly(lactic-co-glycolic acid)), have been used to prepare long-acting formulations of GLP-1 that can extend the release period to weeks with a single dose, reducing injection frequency and improving patient adherence [33]
While meta-analyses suggest a slight association between semaglutide and cholelithiasis, they do not indicate an increased risk of pancreatitis or pancreatic cancer (42)
References This article is based on research from peer-reviewed medical journals, FDA documentation, manufacturer prescribing information, and clinical guidelines
Serious risks like liver dysfunction and anaphylaxis are linked to high-dose, unregulated IV use
En el estudio INTERHEART se confirm la importancia de la obesidad abdominal como FRCV: con casi treinta mil participantes de 52 pases, dicho estudio analiz la contribucin de distintos factores de riesgo y su asociacin con un primer episodio de infarto agudo de miocardio (IAM) y demostr que la obesidad abdominal aumentaba el riesgo incluso ms que la hipertensin o la diabetes (6) (Fig